17-2362114-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014853.3(SGSM2):c.302C>T(p.Pro101Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,611,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014853.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGSM2 | NM_014853.3 | c.302C>T | p.Pro101Leu | missense_variant | 4/24 | ENST00000268989.8 | NP_055668.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGSM2 | ENST00000268989.8 | c.302C>T | p.Pro101Leu | missense_variant | 4/24 | 1 | NM_014853.3 | ENSP00000268989 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000525 AC: 13AN: 247610Hom.: 0 AF XY: 0.0000372 AC XY: 5AN XY: 134298
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1459592Hom.: 0 Cov.: 33 AF XY: 0.0000165 AC XY: 12AN XY: 726234
GnomAD4 genome AF: 0.000256 AC: 39AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.302C>T (p.P101L) alteration is located in exon 4 (coding exon 4) of the SGSM2 gene. This alteration results from a C to T substitution at nucleotide position 302, causing the proline (P) at amino acid position 101 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at